Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 4
2007 4
2008 4
2009 3
2010 5
2012 3
2013 2
2014 3
2015 7
2016 5
2017 11
2018 15
2019 16
2020 16
2021 19
2022 12
Text availability
Article attribute
Article type
Publication date

Search Results

119 results
Results by year
Filters applied: . Clear all
Page 1
Apc-mutant cells act as supercompetitors in intestinal tumour initiation.
van Neerven SM, de Groot NE, Nijman LE, Scicluna BP, van Driel MS, Lecca MC, Warmerdam DO, Kakkar V, Moreno LF, Vieira Braga FA, Sanches DR, Ramesh P, Ten Hoorn S, Aelvoet AS, van Boxel MF, Koens L, Krawczyk PM, Koster J, Dekker E, Medema JP, Winton DJ, Bijlsma MF, Morrissey E, Léveillé N, Vermeulen L. van Neerven SM, et al. Among authors: bijlsma mf. Nature. 2021 Jun;594(7863):436-441. doi: 10.1038/s41586-021-03558-4. Epub 2021 Jun 2. Nature. 2021. PMID: 34079128
Priming the tumor immune microenvironment with chemo(radio)therapy: A systematic review across tumor types.
van den Ende T, van den Boorn HG, Hoonhout NM, van Etten-Jamaludin FS, Meijer SL, Derks S, de Gruijl TD, Bijlsma MF, van Oijen MGH, van Laarhoven HWM. van den Ende T, et al. Among authors: bijlsma mf. Biochim Biophys Acta Rev Cancer. 2020 Aug;1874(1):188386. doi: 10.1016/j.bbcan.2020.188386. Epub 2020 Jun 12. Biochim Biophys Acta Rev Cancer. 2020. PMID: 32540465 Free article.
Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma: A Single-arm Phase II Feasibility Trial (PERFECT).
van den Ende T, de Clercq NC, van Berge Henegouwen MI, Gisbertz SS, Geijsen ED, Verhoeven RHA, Meijer SL, Schokker S, Dings MPG, Bergman JJGHM, Haj Mohammad N, Ruurda JP, van Hillegersberg R, Mook S, Nieuwdorp M, de Gruijl TD, Soeratram TTD, Ylstra B, van Grieken NCT, Bijlsma MF, Hulshof MCCM, van Laarhoven HWM. van den Ende T, et al. Among authors: bijlsma mf. Clin Cancer Res. 2021 Jun 15;27(12):3351-3359. doi: 10.1158/1078-0432.CCR-20-4443. Epub 2021 Jan 27. Clin Cancer Res. 2021. PMID: 33504550 Clinical Trial.
Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial.
van Hilst J, de Rooij T, Bosscha K, Brinkman DJ, van Dieren S, Dijkgraaf MG, Gerhards MF, de Hingh IH, Karsten TM, Lips DJ, Luyer MD, Busch OR, Festen S, Besselink MG; Dutch Pancreatic Cancer Group. van Hilst J, et al. Lancet Gastroenterol Hepatol. 2019 Mar;4(3):199-207. doi: 10.1016/S2468-1253(19)30004-4. Epub 2019 Jan 24. Lancet Gastroenterol Hepatol. 2019. PMID: 30685489 Clinical Trial.
Molecular subtypes in cancers of the gastrointestinal tract.
Bijlsma MF, Sadanandam A, Tan P, Vermeulen L. Bijlsma MF, et al. Nat Rev Gastroenterol Hepatol. 2017 Jun;14(6):333-342. doi: 10.1038/nrgastro.2017.33. Epub 2017 Apr 12. Nat Rev Gastroenterol Hepatol. 2017. PMID: 28400627 Review.
Epigenetic regulation of the Hedgehog and Wnt pathways in cancer.
Wils LJ, Bijlsma MF. Wils LJ, et al. Among authors: bijlsma mf. Crit Rev Oncol Hematol. 2018 Jan;121:23-44. doi: 10.1016/j.critrevonc.2017.11.013. Epub 2017 Nov 24. Crit Rev Oncol Hematol. 2018. PMID: 29279097 Free article. Review.
119 results